The
European Biotechnology Crossroads, October 15-16 at Lille Grand Palais,
takes its place in the top three European biotechnology events
340 confirmed exhibitors, 160 companies
at the business convention, and an expected 2,500 conference attendees
will make the European Biotechnology Crossroads 2002 one of the most
important events in the European biotech calendar.
Paris, October 1st 2002 - The success of the European Biotechnology
Crossroads 2002 places it among the leading European biotechnology
events, the organizers announced today. With 340 exhibitors, 160
businesses signed up for the business convention, and a further 2,500
attendees expected, the European Biotechnology Crossroads believes it is
now one of the top three biggest events in the European biotechnology
calendar.
As one of the only events in its field to
combine an exhibition, conferences and a business convention, the
European Biotechnology Crossroads has aroused high levels of interest in
each of these areas. Organizers say each event category rates first or
second out of the most important European conferences.
"We wanted to make the Biotechnology Crossroads a truly European
event, and we have achieved this aim," said Etienne Vervaecke,
Director of Eurasanté and Coordinator of the European Biotechnology
Crossroads. "The 2002 Crossroads will welcome three times more
exhibitors than last year, adding a whole new dimension to the event. It
also highlights the importance of biotechnology in France. All
indications are that attendee numbers will be very high, and these
figures show that Lille is seen throughout Europe as a hotbed of
biotechnology activity. We are delighted with what is happening, and are
concentrating on making sure October 15-16 will be highly
successful."
The European Biotechnology Crossroads 2003 will take place in Nantes,
September 25-26, 2003, and will be organized by Atlanpole.
Journalists can attend the conferences and
gain entry to the exhibition hall for free, by completing the online
registration form at www.biotech-lille.com
. A downloadable hotel reservation form is also available in the online
press room.
About the European Biotechnology Crossroads:
The European Biotechnology Crossroads is an annual event that aims to
become the main event of the year for the European biotech sector. The
sixth annual conference will take place at the Grand Palais, Lille, on
October 15 and 16 2002. It will bring together different strands of the
French biotech sector as well as a significant number of key figures
from biotechnology institutions across the rest of Europe.
The European Biotechnology Crossroads comprises:
* A programme of international-class scientific presentations over two
days with more than 100 speakers from 10 different countries
* The biggest annual professional European
biotech show (more than 340 international exhibitors in 2002
representing more than 20 countries).
* A business convention bringing together more than 160 European
investors and businesses
The European Biotechnology Crossroads is supported by sponsors
including:
Amgen, ANVAR, Banque Populaire, Caisse des dépôts
et consignations, Club ALFA, Crédit du Nord, Ernst and Young, EuropaBio,
Aventis Foundation- Institute of France, France Biotech, LFB (French
enterprise for biotech research), Jouan, Schering and Tecan.
About Eurasanté:
Eurasanté is the agency for the economic development of
biotech-healthcare activity in the Nord-Pas de Calais region. The
Eurasanté business and research centre brings together 75 businesses
from the biotech and biomedical sectors, seven hospitals, three
colleges, 50 research laboratories and more than 3,500
biotech-healthcare professionals.
For further information:
Andrew Lloyd
Andrew Lloyd & Associates
+44 1273 675 100
allo@ala.com
Keren Perrott
Andrew Lloyd & Associates
+44 1273 675 100
--
Keren Perrott
ANDREW LLOYD & ASSOCIATES
Brighton Business Centre
95 Ditchling Road
Brighton BN1 4ST
United Kingdom
Tel: +44-1273 675100
Fax: +44-1273 675400
55 rue Boissonade
75014 Paris
France
Tel: +33-1 56 54 07 00
Fax: +33-1 56 54 07 01
email: keren@ala.com
http://www.ala.com
